Provided By GlobeNewswire
Last update: Jun 11, 2025
All three patients treated with FT819 following fludarabine-free conditioning regimen for severe lupus nephritis achieve Primary Efficacy Renal Response (PERR); first patient to reach 1-year follow-up continues in drug-free Definition of Remission in SLE (DORIS)
Read more at globenewswire.com1.09
+0.02 (+1.87%)
Find more stocks in the Stock Screener